208 related articles for article (PubMed ID: 34264658)
1. Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes.
Eduful BJ; O'Byrne SN; Temme L; Asquith CRM; Liang Y; Picado A; Pilotte JR; Hossain MA; Wells CI; Zuercher WJ; Catta-Preta CMC; Zonzini Ramos P; Santiago AS; Couñago RM; Langendorf CG; Nay K; Oakhill JS; Pulliam TL; Lin C; Awad D; Willson TM; Frigo DE; Scott JW; Drewry DH
J Med Chem; 2021 Aug; 64(15):10849-10877. PubMed ID: 34264658
[TBL] [Abstract][Full Text] [Related]
2. Using the fluorescent properties of STO-609 as a tool to assist structure-function analyses of recombinant CaMKK2.
Gerner L; Munack S; Temmerman K; Lawrence-Dörner AM; Besir H; Wilmanns M; Jensen JK; Thiede B; Mills IG; Morth JP
Biochem Biophys Res Commun; 2016 Jul; 476(2):102-7. PubMed ID: 27178209
[TBL] [Abstract][Full Text] [Related]
3. In Depth Analysis of Kinase Cross Screening Data to Identify CAMKK2 Inhibitory Scaffolds.
O'Byrne SN; Scott JW; Pilotte JR; Santiago ADS; Langendorf CG; Oakhill JS; Eduful BJ; Couñago RM; Wells CI; Zuercher WJ; Willson TM; Drewry DH
Molecules; 2020 Jan; 25(2):. PubMed ID: 31941153
[TBL] [Abstract][Full Text] [Related]
4. 1,2,6-Thiadiazinones as Novel Narrow Spectrum Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CaMKK2) Inhibitors.
Asquith CRM; Godoi PH; Couñago RM; Laitinen T; Scott JW; Langendorf CG; Oakhill JS; Drewry DH; Zuercher WJ; Koutentis PA; Willson TM; Kalogirou AS
Molecules; 2018 May; 23(5):. PubMed ID: 29783765
[TBL] [Abstract][Full Text] [Related]
5. CaMKK2 is not involved in contraction-stimulated AMPK activation and glucose uptake in skeletal muscle.
Negoita F; Addinsall AB; Hellberg K; Bringas CF; Hafen PS; Sermersheim TJ; Agerholm M; Lewis CTA; Ahwazi D; Ling NXY; Larsen JK; Deshmukh AS; Hossain MA; Oakhill JS; Ochala J; Brault JJ; Sankar U; Drewry DH; Scott JW; Witczak CA; Sakamoto K
Mol Metab; 2023 Sep; 75():101761. PubMed ID: 37380024
[TBL] [Abstract][Full Text] [Related]
6. Binding and structural analyses of potent inhibitors of the human Ca
Profeta GS; Dos Reis CV; Santiago ADS; Godoi PHC; Fala AM; Wells CI; Sartori R; Salmazo APT; Ramos PZ; Massirer KB; Elkins JM; Drewry DH; Gileadi O; Couñago RM
Sci Rep; 2019 Nov; 9(1):16452. PubMed ID: 31712618
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.
York B; Li F; Lin F; Marcelo KL; Mao J; Dean A; Gonzales N; Gooden D; Maity S; Coarfa C; Putluri N; Means AR
Sci Rep; 2017 Sep; 7(1):11793. PubMed ID: 28924233
[TBL] [Abstract][Full Text] [Related]
8. An orally available, brain-penetrant CAMKK2 inhibitor reduces food intake in rodent model.
Price DJ; Drewry DH; Schaller LT; Thompson BD; Reid PR; Maloney PR; Liang X; Banker P; Buckholz RG; Selley PK; McDonald OB; Smith JL; Shearer TW; Cox RF; Williams SP; Reid RA; Tacconi S; Faggioni F; Piubelli C; Sartori I; Tessari M; Wang TY
Bioorg Med Chem Lett; 2018 Jun; 28(10):1958-1963. PubMed ID: 29653895
[TBL] [Abstract][Full Text] [Related]
9. CaMKK2 kinase domain interacts with the autoinhibitory region through the N-terminal lobe including the RP insert.
Kylarova S; Psenakova K; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2304-2313. PubMed ID: 30053538
[TBL] [Abstract][Full Text] [Related]
10. Protein ligand interaction analysis against new CaMKK2 inhibitors by use of X-ray crystallography and the fragment molecular orbital (FMO) method.
Takaya D; Niwa H; Mikuni J; Nakamura K; Handa N; Tanaka A; Yokoyama S; Honma T
J Mol Graph Model; 2020 Sep; 99():107599. PubMed ID: 32348940
[TBL] [Abstract][Full Text] [Related]
11. Akt activation by Ca
Gocher AM; Azabdaftari G; Euscher LM; Dai S; Karacosta LG; Franke TF; Edelman AM
J Biol Chem; 2017 Aug; 292(34):14188-14204. PubMed ID: 28634229
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL; Waddell S; Racioppi L; Long F; Novack DV; Voor MJ; Sankar U
J Bone Miner Res; 2013 Jul; 28(7):1599-610. PubMed ID: 23408651
[TBL] [Abstract][Full Text] [Related]
13. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) inhibitors: a novel approach in small molecule discovery.
Devasahayam Arokia Balaya R; Chandrasekaran J; Kanekar S; Kumar Modi P; Dagamajalu S; Gopinathan K; Raju R; Prasad TSK
J Biomol Struct Dyn; 2023; 41(24):15196-15206. PubMed ID: 37029757
[TBL] [Abstract][Full Text] [Related]
14. 14-3-3 protein directly interacts with the kinase domain of calcium/calmodulin-dependent protein kinase kinase (CaMKK2).
Psenakova K; Petrvalska O; Kylarova S; Lentini Santo D; Kalabova D; Herman P; Obsilova V; Obsil T
Biochim Biophys Acta Gen Subj; 2018 Jul; 1862(7):1612-1625. PubMed ID: 29649512
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A negatively regulates VEGF-induced AMPK activation by phosphorylating CaMKK2 at serine 495.
Spengler K; Zibrova D; Woods A; Langendorf CG; Scott JW; Carling D; Heller R
Biochem J; 2020 Sep; 477(17):3453-3469. PubMed ID: 32869834
[TBL] [Abstract][Full Text] [Related]
16. Structural Analysis of Inhibitor Binding to CAMKK1 Identifies Features Necessary for Design of Specific Inhibitors.
Santiago ADS; Couñago RM; Ramos PZ; Godoi PHC; Massirer KB; Gileadi O; Elkins JM
Sci Rep; 2018 Oct; 8(1):14800. PubMed ID: 30287839
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivation of MEK/ERK pathway by Ca
Najar MA; Aravind A; Dagamajalu S; Sidransky D; Ashktorab H; Smoot DT; Gowda H; Prasad TSK; Modi PK; Chatterjee A
Mol Carcinog; 2021 Nov; 60(11):769-783. PubMed ID: 34437731
[TBL] [Abstract][Full Text] [Related]
18. Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties.
MacDonald AF; Bettaieb A; Donohoe DR; Alani DS; Han A; Zhao Y; Whelan J
BMC Complement Altern Med; 2018 Jun; 18(1):188. PubMed ID: 29914450
[TBL] [Abstract][Full Text] [Related]
19. CaMKK2 is inactivated by cAMP-PKA signaling and 14-3-3 adaptor proteins.
Langendorf CG; O'Brien MT; Ngoei KRW; McAloon LM; Dhagat U; Hoque A; Ling NXY; Dite TA; Galic S; Loh K; Parker MW; Oakhill JS; Kemp BE; Scott JW
J Biol Chem; 2020 Nov; 295(48):16239-16250. PubMed ID: 32913128
[TBL] [Abstract][Full Text] [Related]
20. IGFBP-2 stimulates calcium/calmodulin-dependent protein kinase kinase 2 activation leading to AMP-activated protein kinase induction which is required for osteoblast differentiation.
Xi G; D'Costa S; Wai C; Xia SK; Cox ZC; Clemmons DR
J Cell Physiol; 2019 Dec; 234(12):23232-23242. PubMed ID: 31155724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
